Patanol and Zaleplon drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Patanol (olopatadine hydrochloride) and Zaleplon (zaleplon). Common drug interactions include autonomic nervous system imbalance among females.
The phase IV clinical study analyzes what interactions people have when they take Patanol and Zaleplon. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Patanol?
Patanol has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 5,339 Patanol users. Check the latest studies of Patanol.
What is Zaleplon?
Zaleplon has active ingredients of zaleplon. It is often used in insomnia. eHealthMe is studying from 1,935 Zaleplon users. Check the latest studies of Zaleplon.
15 people who take Patanol and Zaleplon together, and have interactions are studied.

What are the common drug interactions of Patanol and Zaleplon, by gender? *:
female:
- Autonomic nervous system imbalance (autonomic nervous system is of net equal emphasis)
- Fall
- Depression
- Jaw disorder (jaw disease)
- Migraine (headache)
- Pancreatic carcinoma (pancreatic cancer)
- Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
- Surgery
- Tooth disorder (tooth disease)
- Death
male:
n/a
What are the common drug interactions of Patanol and Zaleplon, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Drug administration error
- Poor venous access
40-49:
n/a
50-59:
- Death
- Dyskinesia (abnormality or impairment of voluntary movement)
- Pancreatic carcinoma (pancreatic cancer)
- Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
- Tremor (trembling or shaking movements in one or more parts of your body)
60+:
n/a
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 40.00%
- Apnea (temporary absence or cessation of breathing): 4 people, 26.67%
- Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Patanol and Zaleplon?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Patanol and Zaleplon:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Patanol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zaleplon:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Patanol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zaleplon and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on olopatadine hydrochloride and zaleplon (the active ingredients of Patanol and Zaleplon, respectively), and Patanol and Zaleplon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Fish Oil cause Hallucination, Visual? - 3 seconds ago
- Drug interactions of Perindopril Erbumine and Tamsulosin Hydrochloride - 16 seconds ago
- Could Flax Seed cause Weakness? - 35 seconds ago
- Could Duexis cause Surgery? - 40 seconds ago
- Could Wakix cause Diabetes? - 47 seconds ago
- Could Vytorin cause Bone Pain Aggravated? - 55 seconds ago
- Drug interactions of Penicillin and Qvar - a minute ago
- Drug interactions of Megace and Lactulose - a minute ago
- Diovan Hct vs. Cardura Xl, side effect and effectiveness comparison - a minute ago
- Could Ferrous Fumarate cause Cardiac Failure Aggravated? - a minute ago